While better technology and screening practices have led to the detection of more breast cancers in women—many of which fall into a broad category of early-stage cancer, including ductal carcinoma in situ or DCIS—researchers still do not understand why some of these early cancers remain idle, while others progress. With the support of a new, $3.7 million federal grant from the National Cancer Institute (NCI), an interdisciplinary team of researchers at the University of Vermont (UVM) Cancer Center will be looking to answer this question.

Full story >>